Influences of Diet and Nutrition on Clinical Pharmacokinetics

Clinical Pharmacokinetics

Volumn 14, Issue 6, 1988, Pages 325-346

  Anderson, Karl E ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; MIXED FUNCTION OXIDASE; THEOPHYLLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; DIET; DRUG METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MALNUTRITION; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; AGED; AVITAMINOSIS; BIOLOGICAL AVAILABILITY; CHILD; COOKERY; DIET; FEMALE; FOOD; HUMAN; MALE; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PHARMACOKINETICS;

EID: 0023792989     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-198814060-00002     Document Type: Review

References (150)

1. Drug disposition in obese humans: an update
2. Individual differences in the disposition of drugs metabolised in the body
3. Interactions between nutritional factors and biotransformations in man
4. Intraindividual variation in drug disposition
5. Drug-nutrient interrelationships and the elderly
6. Studies in porphyria, V: drug oxidation rates in hereditary hepatic porphyria
7. Nutrition and oxidative drug metabolism in man: relative influence of dietary lipids, carbohydrate, and protein
8. Nutritional influences on chemical biotransformations in humans
9. Hormones and liver function
10. The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects
11. Diethormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and Cortisol and their respective binding globulins in man
12. Acetaminophen metabolism in subjects fed charcoal-broiled beef
13. Comparative effects of indole and aminoacetonitrile derivatives on dimethylnitrosamine-demethylase and aryl hydrocarbon hydroxylase activities
14. Additive effects of phenobarbital and high protein diet on liver growth in immature male rats
15. Antipyrine metabolism in anorexia nervosa
16. Ascorbic acid deficiency in liver disease
17. Dietary minerals and drug metabolism
18. Hormonal responses to short term fasting in postmenopausal women
19. The effect of dietary protein on the clearance of allopurinol and oxypurinol
20. Antipyrine metabolism in acute intermittent porphyria in relapse and remission
21. Effects of vitamin C on caffeine pharmacokinetics in young and aged guinea pigs
22. Impairment of bilirubin transport as a cause of sulfobromophthalein retention in fasting men
23. Drug metabolism in white vegetarians
24. Acetanilide pharmacokinetics in kwashiorkor
25. Antipyrine pharmacokinetics and D-glucoric excretion in kwashiorkor
26. Isoniazid pharmacokinetics in kwashiorkor
27. Pharmacology of malnutrition, III: binding of digoxin to normal and kwashiorkor serum
28. Role of nutrition in the drug-metabolizing enzyme system
29. Induction of microsomal cytochrome P-450 enzymes: the first Bernard B. Brodie lecture at Pennsylvania State University
30. Metabolic interactions between L-ascorbic acid and drugs
31. Regulation of human drug metabolism by dietary factors
32. Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef
33. Metabolic modification of some neurologic disorders
34. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine
35. Studies on theobromine disposition in normal subjects
36. Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entities
37. Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status
38. Disposition of propranolol, VI: independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man
39. Effects of indole and tryptophan on cytochrome P-450, dimethylnitrosamine demethylase, and arylhydrocarbon hydroxylase activities
40. Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet
41. Drug metabolism in liver disease, identification of patients with impaired hepatic drug metabolism
42. Lack of a clinically important interaction between warfarin and ascorbic acid
43. Effect of dietary protein and carbohydrate on theophylline metabolism in children
44. Interaction between nutrition and theophylline metabolism in children
45. Effect of changes in dietary components on the serum bilirubin in Gilbert’s syndrome
46. Effect of malnutrition on the metabolism of sex hormones in man
47. Factors affecting antipyrine metabolism in West African villagers
48. Environmental effects on antipyrine half-life in man
49. Vitamin C-status and pharmacokinetic profile of antipyrine in man
50. Drug disposition in old age
51. Food and drug fads among the elderly
52. Ascorbic acid in drug metabolism
53. Lack of effect of subclinical ascorbic acid deficiency upon antipyrine metabolism in man
54. Drug metabolism in malnourished children: a study with antipyrine
55. The induction of a specific form of cytochrome P-450 (P-450j) by fasting
56. Ascorbic acid requirement for the induction of microsomal drug-metabolizing enzymes in a rat mutant unable to synthesize ascorbic acid
57. Effect of vitamin C supplement on antipyrine disposition in man
58. Modification of drug biotransformation by vitamin C in man
59. Drug biotransformation interactions in man. VI: Acetaminophen and ascorbic acid
60. 1-acid glycoprotein
61. Lack of ageing effect on human microsomal monooxygenase enzyme activities and on inactivation pathways for reactive metabolic intermediates
62. Decreased theophylline half-life in cigarette smokers
63. Effects of dietary protein on theophylline pharmacokinetic and caffeine and aminopyrine breath tests
64. Effect of charcoal-broiled beef on antipyrine and theophylline metabolism
65. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man
66. The porphyrias
67. Hepatic microsomal drug metabolizing enzymes in aged rats: history and future problems
68. Alterations in pentobarbital pharmacokinetics in response to parenteral and enteral alimentation in the rat
69. Effects of parenteral and enteral hyperalimentation on hepatic drug metabolism in the rat
70. Effects of malnutrition on drug metabolism and toxicity in humans
71. Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects
72. Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine
73. The effect of malnutrition on the pharmacokinetics of phenylbutazone
74. Similarities between oxidative drug-metabolizing enzymes and steroid hydroxylases in liver microsomes
75. Phenacetin metabolism: effects of hydrocarbons and cigarette smoking
76. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation
77. Effect of carbohydrate supplementation on reproductive hormones during fasting in men
78. Cigarette abstinence, nicotine gum, and theophylline disposition
79. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy
80. Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation
81. Benzo(a)pyrene and other polynuclear hydrocarbons in charcoal-broiled meat
82. Arylhydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants
83. Cigarette smoking and urinary estrogens
84. Pharmacokinetics of levonorgestrel in Indian women belonging to low socio-economic group
85. Drug disposition in children with protein energy malnutrition
86. Chloramphenicol metabolism in children with protein-calorie malnutrition
87. Influence of food on the bioavailability of drugs
88. Enhancement of the bioavailability of propranolol and metoprolol by food
89. Protein intake and treatment of Parkinson’s disease with levodopa
90. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking
91. Polymorphism of theophylline metabolism in man
92. Influence of methylxanthine-containing foods on theophylline metabolism and kinetics
93. The influence of changes in dietary fat on the clearance of antipyrine and 4-hydroxylation of debrisoquine
94. Drug oxidation in Asian vegetarians
95. Clinical pharmacokinetics of allopurinol
96. Pharmacokinetic study of antipyrine in malnourished children
97. Acetaminophen hepatotoxicity and malnutrition
98. The ‘on-off’ phenomenon in Parkinson’s disease: relation to levodopa absorption and transport
99. Nutritional status and anthra-cycline cardiotoxicity in children
100. Antipyrine and propranolol disposition in malnutrition
101. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis
102. Effect of age and sex on human drug metabolism
103. Iron deficiency, anaemia and drug metabolism
104. Effect of amino acids and inducers on the activity of the microsomal mono-oxygenase system in rat liver cell culture
105. Stimulatory effect of vegetables on intestinal drug metabolism in the rat
106. Effect of cigarette smoking on phenacetin metabolism
107. Effect of brussels sprouts and cabbage on drug conjugations in humans
108. Stimulatory effect of brussels sprouts and cabbage on human drug metabolism
109. Effects of parenteral nutritional regimens on oxidative drug metabolism
110. Stimulation of oxidative drug metabolism by parenteral refeeding of nutritionally depleted patients
111. The influence of dieting on the menstrual cycle of healthy young women
112. Rifampicin kinetics in undernutrition
113. Pharacokinetics of norethindrone in Indian women
114. Pharmacokinetics and plasma steady state levels of doxycycline in undernutrition
115. Obesity and fasting: effects on drug metabolism and drug action in man
116. Rate of metabolism in obese volunteers before and during starvation and in azotemic patients
117. Unaltered metabolism of antipyrine and tolbutamide in fasting man
118. Interactions between drugs and nutrients
119. Malnutrition among hospitalized patients: a problem of physician awareness
120. Metabolism of foreign compounds by gastrointestinal microorganisms
121. Subcellular and molecular mechanisms underlying the age-related decline in liver drug metabolism
122. Undernutrition and tetracycline half life
123. Metabolism of sulphadiazine in malnutrition
124. Diet-induced alterations in theobromine disposition and toxicity in the rat
125. Effects of tryptophan on protein synthesis by liver
126. Cortisol metabolism and the pituitary-adrenal axis in adults with protein-calorie malnutrition
127. The pituitary-gonadal axis in men with protein-calorie malnutrition
128. The effect of vitamin supplementation upon antipyrine metabolism in the elderly
129. Salicylamide metabolism in acute intermittent porphyria
130. The effect of diet upon serum concentrations of theophylline
131. The effect of vitamin C on the pharmacokinetics of caffeine in elderly men
132. Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation
133. Pharmacokinetics in the elderly
134. The influence of hormonal and nutritional factors on the regulation of liver heme biosynthesis
135. BSP retention during total fasting
136. Dynamic interactions among host factors that influence antipyrine metabolism: implications for the design and interpretation of studies on ethnic pharmacokinetic variations
137. Genetic control of drug levels in man: antipyrine
138. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man
139. Failure of cola nut chewing to alter antipyrine disposition in normal male subjects from a small town in South Central Pennsylvania
140. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking
141. Effects of age and cigarette smoking on propanolol disposition
142. Delayed pituitary hormone response to LRF and TRF in patients with anorexia nervosa and with secondary amenorrhea associated with simple weight loss
143. Lipids in drug detoxication
144. Single dose disposition of choroquine in kwashiorkor and normal children: evidence for decreased absorption in kwashiorkor
145. Influence of food and diet on gastrointestinal drug absorption: a review
146. Influence of diet and fluid on bioavailability of theophylline
147. Modulation of Benzo[a]pyrene metabolism by dietary sulfur amino acids
148. Drug disposition and liver disease
149. Failure of vitamin C to affect the pharmacokinetic profile of antipyrine in man
150. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination